RB Capital Management, LLC
Source: SEC Form 13F · as of Mar 2026RB Capital Management, LLC holds 14 biotech & pharma companies tracked by BioSniper, totaling $26.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$26.2M
| Company | Shares | Value |
|---|---|---|
| AMGNAMGEN INC | 16,083 | $5.7M |
| ABTABBOTT LABORATORIES | 51,428 | $5.3M |
| LLYELI LILLY & Co | 4,820 | $4.4M |
| ABBVAbbVie Inc. | 14,916 | $3.2M |
| JNJJOHNSON & JOHNSON | 10,115 | $2.5M |
| PMPhilip Morris International Inc | 11,020 | $1.8M |
| AZNASTRAZENECA PLC | 5,380 | $1.1M |
| SGMTSagimet Biosciences Inc. | 97,000 | $507K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,513 | $409K |
| MRKMerck & Co., Inc. | 3,383 | $407K |
| GEHCGE HealthCare Technologies Inc. | 4,391 | $313K |
| PFEPFIZER INC | 10,062 | $283K |
| MCKMcKesson Corporation | 245 | $212K |
| BDTXBlack Diamond Therapeutics, Inc. | 35,000 | $75K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.